Similarly, the lower respiratory microbiome, including the lung microbiome, shows decreased diversity in ARDS patients without COVID-19, with increased abundance of Staphylococcus, Streptococcus, and Enterobacterales species and increased IL-6 levels [38]. This evidence concerns the gene IL6 and COVID-19.